Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases

Accounts of Chemical Research

Volumn 41, Issue 1, 2008, Pages 120-129

  Low, Philip S ^a   Henne, Walter A ^a   Doorneweerd, Derek D ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CELL SURFACE RECEPTOR; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; HUMAN; NEOPLASM;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; DRUG DESIGN; FOLIC ACID; HUMANS; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 38949215454     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar7000815     Document Type: Article

References (61)

1. Salazar, M. D.; Ratnam, M. The folate receptor: What does it promise in tissue-targeted therapeutics. Cancer Metastasis Rev 2007, 26, 141-152.
2. Low, P. S.; Antony, A. C. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv. Drug Delivery Rev. 2004, 56, 1055-1231.
3. Chintalacharuvu, S.; Evans, G. F.; Shih, C.; Bryant, H. U.; Sandusky, G. E.; Zuckerman, S. H. Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis. Clin. Exp. Rheumatol. 2005, 23, 438-446.
4. Gibbs, D. D.; Theti, D. S.; Wood, N.; Green, M.; Raynaud, F.; Valenti, M.; Forster, M. D.; Mitchell, F.; Bavetsias, V.; Henderson, E.; Jackman, A. L. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to α-folate receptor-overexpressing tumors. Cancer Res. 2005, 65, 11721-11728.
5. Jackman, A. L.; Theti, D. S.; Gibbs, D. D. Antifolates targeted specifically to the folate receptor. Adv. Drug Delivery Rev. 2004, 56, 1111-1125.
6. Nagayoshi, R.; Nakamura, M.; Ijiri, K.; Yoshida, H.; Komiya, S.; Matsuyama, T. LY309887, antifolate via the folate receptor suppresses murine type II collagen-induced arthritis. Clin. Exp. Rheumatol. 2003, 21, 719-725.
7. Theti, D. S.; Bavetsias, V.; Skelton, L. A.; Titley, J.; Gibbs, D.; Jansen, G.; Jackman, A. L. Selective delivery of CB300638, a cyclopenta[(g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the α-isoform of the folate receptor. Cancer Res. 2003, 63, 3612-3618.
8. Horn, M. A.; Heinstein, P. F.; Low, P. S. Receptor-mediated endocytosis in plant cells. Plant Cell 1989, 1, 1003-1009.
9. Horn, M. A.; Heinstein, P. F.; Low, P. S. Characterization of parameters influencing receptor-mediated endocytosis in cultured soybean cells. Plant Physiol. 1992, 98, 673-679.
10. Wangensteen, O. D.; Bartlett, M. M.; James, J. K.; Yang, Z. F.; Low, P. S. Riboflavin-enhanced transport of serum albumin across the distal pulmonary epithelium. Pharm. Res. 1996, 13, 1861-1864.
11. Leamon, C. P.; Low, P. S. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 5572-5576.
12. Antony, A. C.; Kane, M. A.; Portillo, R. M.; Elwood, P. C.; Kolhouse, J. F. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J. Biol Chem. 1985, 260, 14911-14917.
13. Kamen, B. A.; Capdevila, A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 5983-5987.
14. Leamon, C. P.; Low, P. S. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem. J. 1993, 291 (part 3), 855-860.
15. Turek, J. J.; Leamon, C. P.; Low, P. S. Endocytosis of folate-protein conjugates: Ultrastructural localization in KB cells. J. Cell Sci. 1993, 106 (part 1), 423-430.
16. Leamon, C. P.; Pastan, I.; Low, P. S. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J. Biol. Chem. 1993, 268, 24847-24854.
17. Yang, J.; Chen, H.; Vlahov, I. R.; Cheng, J. X.; Low, P. S. Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 13872-13877.
18. Weitman, S. D.; Lark, R. H.; Coney, L. R.; Fort, D. W.; Frasca, V.; Zurawski, V. R., Jr.; Kamen, B. A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992, 52, 3396-3401.
19. Coney, L. R.; Tomassetti, A.; Carayannopoulos, L.; Frasca, V.; Kamen, B. A.; Colnaghi, M. I.; Zurawski, V. R., Jr. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 1991, 51, 6125-6132.
20. Campbell, I. G.; Jones, T. A.; Foulkes, W. D.; Trowsdale, J. Folate-binding protein is a marker for ovarian cancer. Cancer Res. 1991, 51, 5329-5338.
21. Leamon, C. P.; Low, P. S. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 1992, 267, 24966-24971.
22. Lee, R. J.; Low, P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 1994, 269, 3198-3204.
23. Lee, R. J.; Low, P. S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1995, 1233, 134-144.
24. Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Mandelbaum-Shavit, F.; Qazen, M. M.; Zalipsky, S. Targeting folate receptor with folate linked to extremities of polyethylene glycol)-grafted liposomes: In vitro studies. Bioconjugate Chem. 1999, 10, 289-298.
25. Turk, M. J.; Reddy, J. A.; Chmielewski, J. A.; Low, P. S. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim. Biophys. Acta 2002, 1559, 56-68.
26. Lee, R. J.; Wang, S.; Turk, M. J.; Low, P. S. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery. Biosci. Rep. 1998, 18, 69-78.
27. Reddy, J. A.; Low, P. S. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J. Controlled Release 2000, 64, 27-37.
28. Rui, Y.; Wang, S.; Low, P. S.; Thompson, D. H. Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery. J. Am. Chem. Soc. 1998, 120, 11213-11218.
29. Wang, S.; Lee, R. J.; Cauchon, G.; Gorenstein, D. G.; Low, P. S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3318-3322.
30. Reddy, J. A.; Dean, D.; Kennedy, M. D.; Low, P. S. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 1999, 88, 1112-1118.
31. 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl. Med. Biol. 2003, 30, 725-731.
32. 3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nucl. Med. Biol. 2002, 29, 569-573.
33. 99mTc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjugate Chem. 2000, 11, 253-257.
34. 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts. Nucl. Med. Biol. 1999, 26, 23-25.
35. Mathias, C. J.; Wang, S.; Waters, D. J.; Turek, J. J.; Low, P. S.; Green, M. A. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J. Nucl. Med. 1998, 39, 1579-1585.
36. 111In]DTPA- folate for use as a tumor-targeted radiopharmaceutical. Bioconjugate Chem. 1997, 8, 673-679.
37. Turk, M. J.; Breur, G. J.; Widmer, W. R.; Paulos, C. M.; Xu, L. C.; Grote, L. A.; Low, P. S. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum. 2002, 46, 1947-1955.
38. 99mTc-based radiopharmaceutical. Bioconjugate Chem. 2002, 13, 1200-1210.
39. Lee, J. W.; Lu, J. Y.; Low, P. S.; Fuchs, P. L. Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics. Bioorg. Med. Chem. 2002, 10, 2397-2414.
40. Reddy, J. A.; Westrick, E.; Vlahov, I.; Howard, S. J.; Santhapuram, H. K.; Leamon, C. P. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates. Cancer Chemother. Pharmacol. 2006, 58, 229-236.
41. Leamon, C. P.; Reddy, J. A.; Vlahov, I. R.; Vetzel, M.; Parker, N.; Nicoson, J. S.; Xu, L. C.; Westrick, E. Synthesis and biological evaluation of EC72: A new folate-targeted chemotherapeutic. Bioconjugate Chem. 2005, 16, 803-811.
42. Leamon, C. P.; Reddy, J. A.; Vlahov, I. R.; Kleindl, P. J.; Vetzel, M.; Westrick, E. Synthesis and biological evaluation of EC140: A novel folate-targeted vinca alkaloid conjugate. Bioconjugate Chem. 2006, 17, 1226-1232.
43. Vlahov, I. R.; Santhapuram, H. K.; Kleindl, P. J.; Howard, S. J.; Stanford, K. M.; Leamon, C. P. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Bioorg. Med. Chem. Lett. 2006, 16, 5093-5096.
44. Henne, W. A.; Doorneweerd, D. D.; Hilgenbrink, A. R.; Kularatne, S. A.; Low, P. S. Synthesis and activity of a folate peptide camptothecin prodrug. Bioorg. Med. Chem. Lett. 2006, 16, 5350-5355.
45. Lee, R. J.; Wang, S.; Low, P. S. Measurement of endosome pH following folate receptor-mediated endocytosis. Biochim. Biophys. Acta 1996, 1312, 237-242.
46. Yang, J.; Chen, H.; Vlahov, I. R.; Cheng, J. X.; Low, P. S. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. J. Pharmacol. Exp. Ther. 2007, 321, 462-468.
47. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol. Pharmacol. 2004, 66, 1406-1414.
48. Lu, Y.; Low, P. S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol. Immunother. 2002, 51, 153-162.
49. Kennedy, M. D.; Jallad, K. N.; Thompson, D. H.; Ben-Amotz, D.; Low, P. S. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J. Biomed. Opt. 2003, 8, 636-641.
50. Turk, M. J.; Waters, D. J.; Low, P. S. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett. 2004, 213, 165-172.
51. Paulos, C. M.; Turk, M. J.; Breur, G. J.; Low, P. S. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv. Drug Delivery Rev. 2004, 56, 1205-1217.
52. Nakashima-Matsushita, N.; Homma, T.; Yu, S.; Matsuda, T.; Sunahara, N.; Nakamura, T.; Tsukano, M.; Ratnam, M.; Matsuyama, T. Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42, 1609-1616.
53. Paulos, C. M.; Varghese, B.; Widmer, W. R.; Breur, G. J.; Vlashi, E.; Low, P. S. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res. Ther. 2006, 8, R77.
54. Kinne, R. W.; Brauer, R.; Stuhlmuller, B.; Palombo-Kinne, E.; Burmester, G. R. Macrophages in rheumatoid arthritis. Arthritis Res. 2000, 2, 189-202.
55. Kmiec, Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 2001, 161 (3-13), 1-151.
56. Richard-Miceli, C.; Dougados, M. Tumour necrosis factor-α blockers in rheumatoid arthritis: Review of the clinical experience. BioDrugs 2001, 15, 251-259.
57. Schiff, M. H. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann. Rheum. Dis. 2000, 59 (supplement 1), i103-i108.
58. Goldenberg, M. M. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin. Ther. 1999, 21, 1497-1513, and discussion 1427-1428.
59. Gupta, A. K.; Skinner, A. R. A review of the use of infliximab to manage cutaneous dermatoses. J. Cutan. Med. Surg. 2004, 8, 77-89.
60. Sandoval, R. M.; Kennedy, M. D.; Low, P. S.; Molitoris, B. A. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am. J. Physiol. Cell Physiol. 2004, 287, C517-C526.
61. 18F for PET imaging of folate receptor-positive tumors. J. Nucl. Med. 2006, 47, 1153-1160.